Expression and localization of NOX2 and NOX4 in primary human endothelial cells - PubMed (original) (raw)
. 2005 Mar-Apr;7(3-4):308-17.
doi: 10.1089/ars.2005.7.308.
Affiliations
- PMID: 15706079
- DOI: 10.1089/ars.2005.7.308
Expression and localization of NOX2 and NOX4 in primary human endothelial cells
J D Van Buul et al. Antioxid Redox Signal. 2005 Mar-Apr.
Abstract
Reactive oxygen species (ROS) control the integrity of the vascular endothelium. Our laboratory has recently shown that transduction of human umbilical vein endothelial cells (HUVECs) with an active variant of the small GTPase Rac promotes the production of ROS, ROS-dependent activation of p38 mitogen-activated protein kinase, and loss of vascular/endothelial-cadherin-mediated cell-cell adhesion. Here we show that HUVECs express mRNAs for NOX2 as well as NOX4 mRNA, but not for NOX1 or NOX3. Interestingly, NOX4 was expressed at 100-fold higher levels compared with NOX2. NOX4-green fluorescent protein largely localizes to an intracellular compartment that costained with a marker for the endoplasmic reticulum, and its distribution did not overlap with lysosomes, Weibel-Palade bodies, or mitochondria. The NOX2-regulatory proteins p47(phox) and p67(phox) associated with the actin cytoskeleton and were found in cell protrusions and membrane ruffles, colocalizing with Rac1. This translocation to the cell periphery was promoted by tumor necrosis factor (TNF)-alpha. Finally, scavenging of ROS was found to impair TNF-alpha-induced cytoskeletal rearrangements and the formation of a confluent endothelial monolayer. Together, these data prove the differential mRNA expression of NOX family members in human endothelium and indicate that these NOX proteins and their regulators may be involved in the control of endothelial cell spreading, motility, and cell-cell adhesion.
Similar articles
- NOX2 and NOX4 mediate proliferative response in endothelial cells.
Petry A, Djordjevic T, Weitnauer M, Kietzmann T, Hess J, Görlach A. Petry A, et al. Antioxid Redox Signal. 2006 Sep-Oct;8(9-10):1473-84. doi: 10.1089/ars.2006.8.1473. Antioxid Redox Signal. 2006. PMID: 16987004 - Expression of NADPH oxidases and enhanced H(2)O(2)-generating activity in human coronary artery endothelial cells upon induction with tumor necrosis factor-alpha.
Yoshida LS, Tsunawaki S. Yoshida LS, et al. Int Immunopharmacol. 2008 Oct;8(10):1377-85. doi: 10.1016/j.intimp.2008.05.004. Epub 2008 Jun 4. Int Immunopharmacol. 2008. PMID: 18687299 - Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD(P)H oxidase/Nox2-activation.
Fürst R, Brueckl C, Kuebler WM, Zahler S, Krötz F, Görlach A, Vollmar AM, Kiemer AK. Fürst R, et al. Circ Res. 2005 Jan 7;96(1):43-53. doi: 10.1161/01.RES.0000151983.01148.06. Epub 2004 Nov 29. Circ Res. 2005. PMID: 15569826 - Role of the small GTPase Rac in p22phox-dependent NADPH oxidases.
Miyano K, Sumimoto H. Miyano K, et al. Biochimie. 2007 Sep;89(9):1133-44. doi: 10.1016/j.biochi.2007.05.003. Epub 2007 May 17. Biochimie. 2007. PMID: 17583407 Review. - Endothelial NADPH oxidases: which NOX to target in vascular disease?
Drummond GR, Sobey CG. Drummond GR, et al. Trends Endocrinol Metab. 2014 Sep;25(9):452-63. doi: 10.1016/j.tem.2014.06.012. Epub 2014 Jul 23. Trends Endocrinol Metab. 2014. PMID: 25066192 Review.
Cited by
- NADPH Oxidase 3: Beyond the Inner Ear.
Herb M. Herb M. Antioxidants (Basel). 2024 Feb 8;13(2):219. doi: 10.3390/antiox13020219. Antioxidants (Basel). 2024. PMID: 38397817 Free PMC article. Review. - NADPH Oxidase 4-mediated Alveolar Macrophage Recruitment to Lung Attenuates Neutrophilic Inflammation in Staphylococcus aureus Infection.
Han S, Moon S, Chung YW, Ryu JH. Han S, et al. Immune Netw. 2023 Oct 27;23(5):e42. doi: 10.4110/in.2023.23.e42. eCollection 2023 Oct. Immune Netw. 2023. PMID: 37970233 Free PMC article. - Idiopathic pulmonary fibrosis (IPF): disease pathophysiology, targets, and potential therapeutic interventions.
Saha P, Talwar P. Saha P, et al. Mol Cell Biochem. 2024 Sep;479(9):2181-2194. doi: 10.1007/s11010-023-04845-6. Epub 2023 Sep 14. Mol Cell Biochem. 2024. PMID: 37707699 Review. - Protective effects of paeoniflorin on cardiovascular diseases: A pharmacological and mechanistic overview.
Li X, Sun C, Zhang J, Hu L, Yu Z, Zhang X, Wang Z, Chen J, Wu M, Liu L. Li X, et al. Front Pharmacol. 2023 May 30;14:1122969. doi: 10.3389/fphar.2023.1122969. eCollection 2023. Front Pharmacol. 2023. PMID: 37324475 Free PMC article. Review. - Liraglutide ameliorates oxidized LDL-induced endothelial dysfunction by GLP-1R-dependent downregulation of LOX-1-mediated oxidative stress and inflammation.
Ying W, Meiyan S, Wen C, Kaizu X, Meifang W, Liming L. Ying W, et al. Redox Rep. 2023 Dec;28(1):2218684. doi: 10.1080/13510002.2023.2218684. Redox Rep. 2023. PMID: 37278349 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous